(Q35637836)

English

Possible role for tumour necrosis factor inhibitors in the treatment of resistant dermatomyositis and polymyositis: a retrospective study of eight patients

scientific article published on 13 February 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

9 August 2017

0 references

Possible role for tumour necrosis factor inhibitors in the treatment of resistant dermatomyositis and polymyositis: a retrospective study of eight patients (English)

1 reference

Europe PubMed Central

9 August 2017

0 references

dermatomyositis

0 references

0 references

author name string

P Efthimiou

1

1 reference

Europe PubMed Central

9 August 2017

S Schwartzman

2

1 reference

Europe PubMed Central

9 August 2017

L J Kagen

3

1 reference

Europe PubMed Central

9 August 2017

language of work or name

0 references

publication date

13 February 2006

1 reference

Europe PubMed Central

9 August 2017

Annals of the Rheumatic Diseases

1 reference

Europe PubMed Central

9 August 2017

65

1 reference

Europe PubMed Central

9 August 2017

9

1 reference

Europe PubMed Central

9 August 2017

1233-1236

1 reference

Europe PubMed Central

9 August 2017

Contribution of tumour necrosis factor alpha and interleukin (IL) 1beta to IL6 production, NF-kappaB nuclear translocation, and class I MHC expression in muscle cells: in vitro regulation with specific cytokine inhibitors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1798276

12 July 2018

Polymyositis and dermatomyositis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1798276

12 July 2018

Possible pathogenic mechanisms in inflammatory myopathies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1798276

12 July 2018

Polymyositis and dermatomyositis (first of two parts)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1798276

12 July 2018

Treatment of dermatomyositis and polymyositis with anti-tumor necrosis factor-alpha: long-term follow-up

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1798276

25 September 2018

Treatment of myositis with etanercept (Enbrel), a recombinant human soluble fusion protein of TNF-alpha type II receptor and IgG1.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1798276

25 September 2018

Successful treatment of dermatomyositis and polymyositis with anti-tumor-necrosis-factor-alpha: preliminary observations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1798276

25 September 2018

Tumor necrosis factor-alpha expression in muscles of polymyositis and dermatomyositis

1 reference

https://pubmed.ncbi.nlm.nih.gov/16476710

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

International consensus guidelines for trials of therapies in the idiopathic inflammatory myopathies

1 reference

https://pubmed.ncbi.nlm.nih.gov/16476710

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Associations of Tumor Necrosis Factor α and HLA Polymorphisms with Adult Dermatomyositis: Implications for a Unique Pathogenesi1

1 reference

https://pubmed.ncbi.nlm.nih.gov/16476710

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Elevated serum levels of interleukin-1 receptor antagonist in polymyositis/dermatomyositis. A biologic marker of disease activity with a possible role in the lack of acute-phase protein response

1 reference

https://pubmed.ncbi.nlm.nih.gov/16476710

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Analysis of cytokine expression in muscle in inflammatory myopathies, Duchenne dystrophy, and non-weak controls

1 reference

https://pubmed.ncbi.nlm.nih.gov/16476710

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cytokine expression profile in idiopathic inflammatory myopathies

1 reference

https://pubmed.ncbi.nlm.nih.gov/16476710

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of tumor necrosis factor-alpha in muscles of polymyositis

1 reference

https://pubmed.ncbi.nlm.nih.gov/16476710

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Elevation of serum soluble tumour necrosis factor receptors in patients with polymyositis and dermatomyositis

1 reference

https://pubmed.ncbi.nlm.nih.gov/16476710

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1136/ARD.2005.048744

1 reference

Europe PubMed Central

9 August 2017

1 reference

Europe PubMed Central

9 August 2017

1 reference

Europe PubMed Central

9 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35637836&oldid=1582161324"